Gamida Cell Ltd.

Gamida Cell Ltd. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. Our proprietary nicotinamide (NAM) technology expands the number of cells while maintaining their intrinsic properties to create potentially curative cell therapy products and candidates for patients with cancer. Our stem cell transplant therapy was approved by the US FDA in April 2023. Clinical study of our NK cell therapy candidate GDA-201 is ongoing.

Company Details

Employees
99
Founded
-
Address
673 Boylston St, 4th Floor,israel
Phone
97226595616
Email
ma****@****ell.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Manager jobs.
HQ
Boston, Massachusetts
Looking for a particular Gamida Cell Ltd. employee's phone or email?

Gamida Cell Ltd. Questions

News

Gamida Cell Presents Positive Initial Results on Treating Severe Aplastic Anemia (SAA) with Omidubicel - Yahoo Finance

Gamida Cell Presents Positive Initial Results on Treating Severe Aplastic Anemia (SAA) with Omidubicel Yahoo Finance

RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge® (omidubicel-onlv) - Business Wire

RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge® (omidubicel-onlv) Business Wire

BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd. - PR Newswire

BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd. PR Newswire

Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management - GlobeNewswire

Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management GlobeNewswire

Unable to find a partner for stem cell therapy, Gamida accepts sale to investment firm to survive - Fierce Biotech

Unable to find a partner for stem cell therapy, Gamida accepts sale to investment firm to survive Fierce Biotech

Gamida Cell’s Omisirge Administered to First Patient in Commercial Setting - CGTLive®

Gamida Cell’s Omisirge Administered to First Patient in Commercial Setting CGTLive®

Gamida Cell Announces New Leadership Under Ownership of Highbridge Capital Management - Business Wire

Gamida Cell Announces New Leadership Under Ownership of Highbridge Capital Management Business Wire

Gamida Cell Appoints Vladimir Melnikov as Senior Vice President, Global Operations and Manufacturing - citybiz

Gamida Cell Appoints Vladimir Melnikov as Senior Vice President, Global Operations and Manufacturing citybiz

Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR® - Yahoo Finance

Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR® Yahoo Finance

Gamida Cell Secures World’s 1st FDA Approval for an Expanded Cord Blood Cell Therapy - BioInformant

Gamida Cell Secures World’s 1st FDA Approval for an Expanded Cord Blood Cell Therapy BioInformant

After going all-in on blood cancer therapy, Gamida Cell scores big win at FDA - Fierce Pharma

After going all-in on blood cancer therapy, Gamida Cell scores big win at FDA Fierce Pharma

Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update - GlobeNewswire

Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update GlobeNewswire

Gamida Cell readies stem cell transplant therapy for FDA submission but seeks strategic partners amid staffing cuts - Fierce Biotech

Gamida Cell readies stem cell transplant therapy for FDA submission but seeks strategic partners amid staffing cuts Fierce Biotech

Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting - Yahoo Finance

Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting Yahoo Finance

Gamida Cell Appoints Abigail L. Jenkins as President and Chief Executive Officer, Bringing Broad Leadership Experience in Commercializing Innovative Therapies - Business Wire

Gamida Cell Appoints Abigail L. Jenkins as President and Chief Executive Officer, Bringing Broad Leadership Experience in Commercializing Innovative Therapies Business Wire

Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update - Yahoo Finance

Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update Yahoo Finance

Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration - Business Wire

Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration Business Wire

Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval - Business Wire

Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval Business Wire

Gamida Cell Announces Pricing of $23 Million Public Offering of Securities - Business Wire

Gamida Cell Announces Pricing of $23 Million Public Offering of Securities Business Wire

Gamida Cell files for U.S. bankruptcy as it undergoes restructuring - The Business Journals

Gamida Cell files for U.S. bankruptcy as it undergoes restructuring The Business Journals

Ayrmid Ltd. Announces FDA Acceptance and Priority Review for Omidubicel for the Treatment of Severe Aplastic Anemia (SAA) - Yahoo Finance

Ayrmid Ltd. Announces FDA Acceptance and Priority Review for Omidubicel for the Treatment of Severe Aplastic Anemia (SAA) Yahoo Finance

Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration - BioInformant

Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration BioInformant

Gamida Cell Presents Additional Positive Data of NiCord® in Blood Cancer Patients - BioInformant

Gamida Cell Presents Additional Positive Data of NiCord® in Blood Cancer Patients BioInformant

Why Is Gamida Cell (GMDA) Stock Down 82% Today? - InvestorPlace

Why Is Gamida Cell (GMDA) Stock Down 82% Today? InvestorPlace

Pharma Veteran Julian Adams takes Helm at Gamida Cell - CTech

Pharma Veteran Julian Adams takes Helm at Gamida Cell CTech

Gamida Cell to delist as Highbridge takes full ownership - Globes - Israel Business News

Gamida Cell to delist as Highbridge takes full ownership Globes - Israel Business News

Wiley Joe gets cash injection for struggling stem cell start-up - The Times

Wiley Joe gets cash injection for struggling stem cell start-up The Times

Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Techniq - Hospital Clínic Barcelona

Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Techniq Hospital Clínic Barcelona

Top Gamida Cell Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant